Respiratory Synctial Virus Infections
4 clinical trials · Condition
◉ Watch Respiratory Synctial Virus Infections
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age. (NCT06856967) | Meyer Children's Hospital IRCCS | 2024-12-04 |
| A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants (NCT06775405) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2024-02-29 |
| Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults (NCT06890429) | Research Institute of Influenza, Russia | 2023-12-07 |
| A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults (NCT02491463) | GlaxoSmithKline | 2015-07-23 |
Track Respiratory Synctial Virus Infections automatically
Every clearance here is in the API, with alerts when new ones post.